Effect of CD154:CD11b blockade on antigen-specific CD8 T cell response to murine Epstein-Barr virus infection
RNA-seq (gene expression) · mouse · 10 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 5 × Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol vs 5 × Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, BiolGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- CD154:CD11b blockade enhances CD8+ T cell differentiation during infection but not transplantationJCI insight · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE293467_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1244744 and SRA study SRP575780. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 10 samples.
How we read this: 2 replicated groups read from 10 sample titles; they account for 10 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8882927 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol Rep 1 Mm Spleen, p79/Kb CD8 T…
- GSM8882928 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol Rep 2 Mm Spleen, p79/Kb CD8 T…
- GSM8882929 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol Rep 3 Mm Spleen, p79/Kb CD8 T…
- GSM8882930 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol Rep 4 Mm Spleen, p79/Kb CD8 T…
- GSM8882931 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, No Treatment, Biol Rep 5 Mm Spleen, p79/Kb CD8 T…
- GSM8882932 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, Biol Rep 1 Mm Spleen, p79/Kb CD8 T…
- GSM8882933 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, Biol Rep 2 Mm Spleen, p79/Kb CD8 T…
- GSM8882934 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, Biol Rep 3 Mm Spleen, p79/Kb CD8 T…
- GSM8882935 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, Biol Rep 4 Mm Spleen, p79/Kb CD8 T…
- GSM8882936 Mm Spleen, p79/Kb CD8 T cells, Day 10-Post MHV68 Infection, cM7 Treatment, Biol Rep 5 Mm Spleen, p79/Kb CD8 T…
- GSE337601 XCR1+ and CD11b+ migratory dendritic cells cooperate for the crosspriming of intratumoral CD8+ T cells with a tissue-resident memory phenotype [RNA-Seq] 36 samples shares cd11b, cd8
- GSE285970 IRF4-regulated transcriptional heterogeneity of lung resident CD11b+ cDC2 subsets during influenza virus infection 20 samples shares cd11b, virus
- GSE269347 Daunorubicin-induced T cell remodeling facilitates a high antitumor response to PD-1 blockade therapy by promoting the expansion and effector function of CD8+ prolifeating T cells [scRNA-Seq] 16 samples shares cd8, blockade
- GSE207029 Blockade of avb8 integrin synergizes with checkpoint inhibition to enhance anti-tumor immunity through Cxcl9-dependent augmentation of CD8+ T cell cytotoxicity 12 samples shares cd8, blockade
- GSE279041 Targeting pyruvate metabolism generates distinct CD8+ T cell responses to gammaherpesvirus and B lymphoma 12 samples shares cd8, virus
- GSE291447 Targeting CD11b+ regulatory B cells via RAS/RAF/PI3K pathway inhibition augments response to immune checkpoint blockade or CD40 agonism in metastatic melanoma 60 samples shares cd11b, blockade
- GSE270050 Expansion of Tumor-Infiltrating CD8+ T Cell Clonotypes Occurs in the Spleen in Response to Immune Checkpoint Blockade 29 samples shares cd8, blockade
- GSE307388 Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones in preclinical models of cancer 12 samples shares cd8, blockade
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.